Published on: July 29, 2021 at 09:30PM Condition : Type 2 Diabetes Mellitus With Complication Interventions : Drug: Bifidobacterium, Lactobacillus, Enterococcus and Bacillus Cereus Tablets, Live; Drug: Siliankang simulating tablets Sponsors : Peking Union Medical College Hospital; First Affiliated Hospital of Harbin Medical University; The Affiliated Hospital of Inner Mongolia Medical University; Affiliated Hospital of Chengde Medical University; The First Affiliated Hospital of Zhengzhou University; Chinese Academy of Sciences; Hangzhou Grand Biologic Pharmaceutical, Inc. Not yet recruiting https://ift.tt/3lh8YKm